![]() |
市场调查报告书
商品编码
1904286
一次性生物製程市场规模、份额及成长分析(按产品、应用和地区划分)-2026-2033年产业预测Single Use Bioprocessing Market Size, Share, and Growth Analysis, By Product (Equipment, Single-Use Bioreactors), By Application (Filtration, Cell Culture), By Region - Industry Forecast 2026-2033 |
||||||
预计到 2024 年,一次性生物加工市场价值将达到 177 亿美元,到 2025 年将成长至 202.7 亿美元,到 2033 年将成长至 598.8 亿美元,在预测期(2026-2033 年)内复合年增长率为 14.5%。
一次性生物製程市场正经历显着成长,这主要得益于一次性技术的日益普及,这些技术能够降低设施建设成本和缩短工期。製造业对一次性产品的日益青睐以及先进设备创新的涌现,进一步推动了这一成长动能。新参与企业和老牌供应商都在推出功能强大的一次性解决方案,以增强其在生物製药领域的产品供应。此外,创新自动化技术的整合以及巨量资料分析的进步预计将对市场动态积极影响,并推动一次性生物製程解决方案的需求。总而言之,这些因素都强烈表明该领域具有持续扩张的潜力,并凸显了其在生物工艺领域的关键地位。
一次性生物加工市场驱动因素
全球人口老化预计将显着推动一次性生物製程市场的发展。随着65岁及以上人口数量的持续增长,为满足其医疗需求,对生物製药的需求势必增加。这种人口结构变化正促使製药公司采用一次性生物製程系统,以提高营运效率并降低成本。业界主要企业关注如何利用这些创新系统来满足不断增长的生物製药产品需求,并有效应对老龄化人口的医疗需求。
限制一次性生物加工市场发展的因素
全球一次性生物加工市场的主要限制因素之一是其废弃物处理可能带来的环境影响。儘管这些系统在生物製造方面具有高效性和柔软性,但人们对塑胶废弃物和永续性的担忧可能会阻碍其广泛应用。包括监管机构和具有环保意识的消费者在内的许多相关人员,越来越重视环保方法和材料。这种对永续性的日益关注迫使製造商在营运效率和负责任的废弃物管理之间寻求平衡,这可能会给市场成长带来挑战,因为企业既要满足效率需求,又要兼顾环境问题。
一次性生物製程市场趋势
一次性生物製程市场正经历强劲成长,这主要得益于技术的快速进步和研发领域的巨额投资。这一趋势推动了先进一次性系统的应用和创新,有助于提高生物製造流程的营运效率并降低污染风险。各公司正积极在其产品组合中添加先进的一次性解决方案,以满足对精简高效且经济实惠的生物製程方法日益增长的需求。随着生物製药公司寻求优化产能并应对复杂的监管要求,市场有望充分利用这些发展机会,为生物製程技术领域的相关人员带来盈利的利润。
Single Use Bioprocessing Market size was valued at USD 17.7 Billion in 2024 and is poised to grow from USD 20.27 Billion in 2025 to USD 59.88 Billion by 2033, growing at a CAGR of 14.5% during the forecast period (2026-2033).
The single-use bioprocessing market is experiencing significant growth driven by the increasing popularity of single-use technology, which reduces capital costs and construction time for facilities. The rising adoption of disposable products among manufacturing organizations and a surge in the innovation of advanced devices further fuel this momentum. New market entrants and existing vendors are introducing robust disposable solutions, enhancing product offerings in the biopharmaceutical sector. Additionally, the integration of innovative automation and advancements in big data analytics are poised to positively influence market dynamics, reinforcing the demand for single-use bioprocessing solutions. These factors collectively highlight the strong potential for continued expansion within this sector, underscoring its critical role in the bioprocessing landscape.
Top-down and bottom-up approaches were used to estimate and validate the size of the Single Use Bioprocessing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Single Use Bioprocessing Market Segments Analysis
Global Single Use Bioprocessing Market is segmented by product, application, workflow, molecule type, end user and region. Based on product, the market is segmented into equipment and consumables. Based on application, the market is segmented into filtration, cell culture, mixing, purification, storage & transfer and other. Based on workflow, the market is segmented into upstream bioprocessing and downstream bioprocessing. Based on molecule type, the market is segmented into monoclonal antibodies, vaccines, therapeutic proteins & peptides and cell & gene therapies. Based on end user, the market is segmented into pharmaceutical & biotechnology companies, CROS & CMOS and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Single Use Bioprocessing Market
The increasing global aging population is anticipated to significantly boost the single-use bioprocessing market. As the number of individuals aged 65 and older continues to grow, the demand for biopharmaceuticals will inevitably increase in response to their healthcare needs. This demographic shift is driving pharmaceutical companies to adopt single-use bioprocessing systems, as these technologies enhance operational efficiency and reduce costs. The industry is witnessing a heightened focus from major corporations on leveraging these innovative systems to meet the rising demand for biopharmaceutical products, ensuring that they cater effectively to the healthcare requirements of an aging populace.
Restraints in the Single Use Bioprocessing Market
One key market restraint for the global single-use bioprocessing market is the potential environmental impact associated with the disposal of single-use bioprocessing materials. While these systems offer efficiency and flexibility in biomanufacturing, concerns regarding plastic waste and sustainability can hinder their widespread adoption. Many stakeholders, including regulatory bodies and environmentally-conscious consumers, are increasingly prioritizing eco-friendly practices and materials. This growing emphasis on sustainability may compel manufacturers to balance operational efficiency with responsible waste management, posing challenges for the market growth as companies strive to meet both efficiency needs and environmental considerations.
Market Trends of the Single Use Bioprocessing Market
The single-use bioprocessing market is experiencing robust growth driven by a surge in technological advancements and significant investments in research and development. This trend is fostering increased innovation and the introduction of sophisticated single-use systems, enhancing operational efficiency and reducing contamination risks in biomanufacturing processes. Companies are actively expanding their portfolios to include advanced single-use disposable solutions, responding to the rising demand for streamlined and cost-effective bioprocessing methods. As biopharmaceutical companies seek to optimize production capabilities and navigate regulatory complexities, the market is poised to capitalize on these developments, offering lucrative opportunities for stakeholders in the evolving landscape of bioprocessing technologies.